Evaluation of quality of life of a patient with malignant tumor of the oropharyngeal area during antitumor treatment
- Authors: Izhnina E.V.1,2, Kochurova E.V.1, Lapina N.V.2, Rustamova E.K.2
-
Affiliations:
- I. M. Sechenov First Moscow State Medical University, Ministry of Health of Russia
- Kuban State Medical University, Ministry of Health of Russia
- Issue: Vol 7, No 4 (2017)
- Pages: 41-52
- Section: ORIGINAL REPORT
- Published: 26.12.2017
- URL: https://ogsh.abvpress.ru/jour/article/view/308
- DOI: https://doi.org/10.17650/2222-1468-2017-7-4-41-52
- ID: 308
Cite item
Full Text
Abstract
Introduction. Surgical treatment of patients with malignant neoplasms of the oropharyngeal region less disrupts the functional state of the maxillofacial region, reduces the relapse of diseases and maintains a satisfactory cosmetic result due to modern technologies. However, the future adequate rehabilitation provides a high indicator of the quality of life of such patients during antitumor treatment.
The aim of this study was assessment of the quality of life of the patient with malignant neoplasm of the oropharyngeal region at the pretreatment stages, after surgical treatment with the imposition of an individual temporary prosthesis on the upper jaw, after the fabricate of obturator prosthesis, 3 months after orthopedic rehabilitation.
Materials and methods. The quality of life of a patient with salivary gland cancer (T3N0M0) according to international scales for assessment of dental health of patients with head and neck tumors was analyzed: FACT-H&N, QLQ-C30 H&N35, OHIP-14; and the assessment of general health: SF-36, Karnovsky, ECOG Perfomance Status, EORTC-QLQ-C30.
Results. The results of the evaluation on the questionnaires reflect the same dynamics, but they are not adapted for the analysis of the stages of dental rehabilitation, which is the final link in the treatment of patients with malignant neoplasms of the oropharyngeal region.
Conclusion. The level of quality of life of a patient depends on the methods of orthopedic treatment during antitumor treatment on all scales.
About the authors
E. V. Izhnina
I. M. Sechenov First Moscow State Medical University, Ministry of Health of Russia;Kuban State Medical University, Ministry of Health of Russia
Author for correspondence.
Email: med_stomat@mail.ru
8–2 Trubetskaya St., Moscow 119991, Russia;
4 Sedina St., Krasnodar 350063, Russia
Russian FederationE. V. Kochurova
I. M. Sechenov First Moscow State Medical University, Ministry of Health of Russia
Email: fake@neicon.ru
8–2 Trubetskaya St., Moscow 119991, Russia Russian Federation
N. V. Lapina
Kuban State Medical University, Ministry of Health of Russia
Email: fake@neicon.ru
4 Sedina St., Krasnodar 350063, Russia Russian Federation
E. K. Rustamova
Kuban State Medical University, Ministry of Health of Russia
Email: fake@neicon.ru
4 Sedina St., Krasnodar 350063, Russia Russian Federation
References
Supplementary files


